.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

REMERON SOLTAB Drug Profile

« Back to Dashboard

Which patents cover Remeron Soltab, and what substitute generic drugs are available?

Remeron Soltab is a drug marketed by Organon Usa Inc and is included in one NDA.

The generic ingredient in REMERON SOLTAB is mirtazapine. There are seventeen drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the mirtazapine profile page.

Summary for Tradename: REMERON SOLTAB

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list3
Bulk Api Vendors: see list77
Clinical Trials: see list7
Patent Applications: see list3,034
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:REMERON SOLTAB at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc
REMERON SOLTAB
mirtazapine
TABLET, ORALLY DISINTEGRATING;ORAL021208-001Jan 12, 2001RXYesYes► Subscribe► Subscribe
Organon Usa Inc
REMERON SOLTAB
mirtazapine
TABLET, ORALLY DISINTEGRATING;ORAL021208-002Jan 12, 2001RXYesNo► Subscribe► Subscribe
Organon Usa Inc
REMERON SOLTAB
mirtazapine
TABLET, ORALLY DISINTEGRATING;ORAL021208-003Jan 12, 2001RXYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: REMERON SOLTAB

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc
REMERON SOLTAB
mirtazapine
TABLET, ORALLY DISINTEGRATING;ORAL021208-001Jan 12, 20015,178,878► Subscribe
Organon Usa Inc
REMERON SOLTAB
mirtazapine
TABLET, ORALLY DISINTEGRATING;ORAL021208-002Jan 12, 20015,178,878► Subscribe
Organon Usa Inc
REMERON SOLTAB
mirtazapine
TABLET, ORALLY DISINTEGRATING;ORAL021208-003Jan 12, 20015,178,878► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc